FoXX Health

What FoXX Health does

FoXX Health is a women's health technology company headquartered in Chicago and founded in 2019 by Maria Haugen following her personal experience with misdiagnosis. The company develops a mobile application (available on iOS and Android) that delivers whole-body symptom tracking across pain, skin, cycle, energy, digestion, and mood domains; guided appointment preparation that translates tracked data into clinician-ready summaries; AI-supported pattern recognition over time; and a peer community called The Den organized around specific conditions. The product is co-created with 150+ women including physicians and is officially licensed with the U.S. National Library of Medicine (UMLS, SNOMED CT, RxNorm, NIH CDEs, VSAC), giving it clinical vocabulary that consumer period trackers lack. Infrastructure is being built to HIPAA standards with SOC 2 certification in pursuit.

The company targets women navigating chronic or undiagnosed conditions — endometriosis, PCOS, autoimmune disorders, perimenopause — as well as women seeking better self-advocacy in 12–15 minute clinical appointments. The business model is freemium consumer subscription with auto-renewing monthly or annual billing; specific price points are not publicly disclosed. The roadmap is structured in three phases: Phase 1 (DTC traction and retention, current), Phase 2 (wearable integration and premium tier expansion, announced for 2026), and Phase 3 (clinical distribution through provider dashboards and health system integrations). FoXX is privately held, founder-owned, and currently raising a pre-seed round with no disclosed institutional investors to date.

Name

FoXX Health

Legal name

FoXX Health

Website

https://foxxhealth.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

11–50 employees

Short description

FoXX Health is a women's health technology company that operates a mobile application providing whole-body symptom tracking, AI-assisted pattern recognition, and peer community support for women with chronic or undiagnosed conditions. The app is licensed with the U.S. National Library of Medicine and distributed via iOS and Android app stores under a freemium subscription model.

Ownership category

akta.pro rank

Product category

Women's Health Mobile Application

akta.pro primary industry

Non-prescription / OTC Digital Therapeutics (HLACANAC)

akta.pro secondary industries

Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB), Condition-specific Digital Therapeutics (DTx) (HLACANAA)

Keywords

• Women's health tracking
• Symptom tracking app
• Patient health records
• Chronic care management
• Digital health platform

Headquarters

HQ city

Chicago

HQ country

United States

HQ region

North America

Markets served

GTM type

B2C

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Freemium App Model: Core symptom tracking features available for free; premium subscription unlocks advanced features. Subscriptions automatically renew unless canceled before renewal date. Some features available only with paid subscription.
2. Premium Subscription: Subscription-based revenue with automatic renewal. Pricing and billing cycles displayed at time of purchase. No refunds for partially used billing periods unless required by law.
3. DTC to B2B Clinical Licensing (Future): Phase 3 roadmap includes provider licensing and clinical distribution. Provider dashboards and health system integrations planned as future revenue streams.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels5 records

Core offering

FoXX Health fundamentally offers a direct-to-consumer mobile application (iOS and Android) that enables women to track whole-body symptoms, prepare for medical appointments through guided prompts, and engage with a community. The product is positioned as a freemium app with a premium subscription tier and is licensed with the U.S. National Library of Medicine, with wearable connectivity in development and a future B2B clinical offering planned.

Product overview

FoXX Health offers a single unified mobile application comprising two main integrated components: the core FoXX Health App for full-body symptom tracking, appointment preparation, and health pattern insights, and The Den, an in-app community platform for peer support and condition-specific discussions. The product portfolio is currently focused on direct-to-consumer women's health tracking, with future phases planned for wearable device integration and clinical/provider-facing tools.

Differentiator

Problem solved

Functional benefit

Products and services

• FoXX Health App

Quantifiable outcome

• 93% of women report their symptoms are dismissed by healthcare providers
• +3 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Two partnerships are on record, tiered core.

• U.S. National Library of Medicine / NIHcoreTechnology or IntegrationFoXX Health is officially licensed with the U.S. National Library of Medicine, giving access to UMLS, SNOMED CT, RxNorm, NIH CDEs, and VSAC - the same medical standards healthcare providers use. This licensing provides clinical credibility and a defensible moat, ensuring the app uses medically accurate terminology and standards.
• 150+ Women Advisory ContributorscoreStrategic or Co-development PartnerOver 150 women including patients, advocates, and doctors co-created FoXX from the beginning. The Advisory Committee of 100+ women guides product development through real-world experiences. These women shape the language, features, and priorities of the product based on lived experience.

Scale indicators7 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• Maven Clinic: Maven is a leading virtual care platform dedicated to women's and family health, serving employers and health plans. It represents the B2B clinical destination FoXX aspires to in its Phase 3 roadmap and operates broadly across the women's health stack.
• Elvie: Elvie makes connected women's health hardware (pelvic floor trainer, breast pump) and companion apps. It is a broader incumbent in women's connected health and a plausible Phase 2 wearable-integration partner or competitor for the same demographic.
• Oura: Oura is a smart ring wearable capturing sleep, heart rate, HRV, and temperature with a substantial women's health feature set including cycle and pregnancy insights. It overlaps FoXX's planned Phase 2 wearable biomarker layer and competes for the same women's health wallet.

Emerging players

• Midi Health: Midi Health is a virtual clinic for women in perimenopause and menopause offering clinician-led care. It targets the same chronic women's health conditions FoXX addresses via symptom tracking and competes for provider-side clinical relationships in Phase 3.
• Elektra Health: Elektra Health is a digital menopause care platform combining virtual care with education and community. It competes for the same women's midlife chronic-condition segment that FoXX targets via its whole-body symptom tracker.
• Gennev: Gennev is a telehealth and care platform focused on menopause and perimenopause, combining symptom tracking with clinician access. It overlaps FoXX on the perimenopause and hormonal symptom journeys that drive significant FoXX use cases.
• Allara Health: Allara is a virtual care platform for women with hormonal conditions such as PCOS and endometriosis — two of the highest-burden conditions FoXX explicitly cites. It represents a more clinically integrated competitor for the same end user.

Direct peers

• Natural Cycles: Natural Cycles is an FDA-cleared digital contraceptive app using basal body temperature and symptom data. It is a direct peer in women's health tracking with a regulatory-grade certification that FoXX would need to match for any clinical positioning.
• Clue: Clue is a Berlin-based period and fertility tracking app focused on evidence-based women's health. It directly overlaps FoXX on cycle/symptom tracking and shares the same consumer-female target market with a similarly science-forward brand positioning.
• Flo Health: Flo is the largest direct-to-consumer period and symptom tracking app for women, with tens of millions of monthly active users and significant venture backing. It is the closest direct competitor to FoXX in women's health tracking and the primary benchmark for category scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/FoxxHealth
• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/company/foxxhealth

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about FoXX Health